IL187186A0 - Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors - Google Patents
Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptorsInfo
- Publication number
- IL187186A0 IL187186A0 IL187186A IL18718607A IL187186A0 IL 187186 A0 IL187186 A0 IL 187186A0 IL 187186 A IL187186 A IL 187186A IL 18718607 A IL18718607 A IL 18718607A IL 187186 A0 IL187186 A0 IL 187186A0
- Authority
- IL
- Israel
- Prior art keywords
- metabotropic glutamate
- oxadiazole derivatives
- positive allosteric
- glutamate receptors
- allosteric modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0510138A GB0510138D0 (en) | 2005-05-18 | 2005-05-18 | Novel compounds A4 |
| GBGB0601709.9A GB0601709D0 (en) | 2006-01-27 | 2006-01-27 | Novel compounds A4 |
| PCT/IB2006/001881 WO2006123255A2 (en) | 2005-05-18 | 2006-05-17 | Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL187186A0 true IL187186A0 (en) | 2008-02-09 |
Family
ID=37431638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL187186A IL187186A0 (en) | 2005-05-18 | 2007-11-06 | Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090215822A1 (enExample) |
| EP (1) | EP1893606A2 (enExample) |
| JP (1) | JP2008540635A (enExample) |
| KR (1) | KR20080027463A (enExample) |
| AU (1) | AU2006248655A1 (enExample) |
| BR (1) | BRPI0611423A2 (enExample) |
| CA (1) | CA2608014A1 (enExample) |
| EA (1) | EA015813B1 (enExample) |
| IL (1) | IL187186A0 (enExample) |
| MX (1) | MX2007014444A (enExample) |
| NO (1) | NO20076478L (enExample) |
| NZ (1) | NZ564254A (enExample) |
| WO (1) | WO2006123255A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0510140D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B2 |
| GB0510139D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| GB0510142D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
| GB0510141D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
| US7807706B2 (en) | 2005-08-12 | 2010-10-05 | Astrazeneca Ab | Metabotropic glutamate-receptor-potentiating isoindolones |
| GB0622202D0 (en) * | 2006-11-07 | 2006-12-20 | Addex Pharmaceuticals Sa | Novel compounds |
| TWI417100B (zh) | 2007-06-07 | 2013-12-01 | Astrazeneca Ab | 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途 |
| TW200911255A (en) | 2007-06-07 | 2009-03-16 | Astrazeneca Ab | Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841 |
| SA109300358B1 (ar) | 2008-06-06 | 2012-11-03 | استرازينيكا ايه بي | مقويات مستقبل جلوتامات ذي انتحاء أيضي من أيزو إندولون |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2010098866A1 (en) | 2009-02-27 | 2010-09-02 | Supergen, Inc. | Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors |
| WO2010124055A1 (en) * | 2009-04-23 | 2010-10-28 | Merck Sharp & Dohme Corp. | 2-alkyl piperidine mglur5 receptor modulators |
| CA2784830C (en) | 2009-12-18 | 2018-03-27 | Sunovion Pharmaceuticals Inc. | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| CN102762572A (zh) | 2010-02-01 | 2012-10-31 | 诺瓦提斯公司 | 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物 |
| AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
| EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
| US20130210804A1 (en) * | 2010-10-25 | 2013-08-15 | Neville J. Anthony | Tricyclic mglur5 receptor modulators |
| WO2016065584A1 (en) * | 2014-10-30 | 2016-05-06 | Merck Sharp & Dohme Corp. | Piperidine oxadiazole and thiadiazole orexin receptor antagonists |
| EP3275440B1 (en) * | 2015-03-25 | 2022-05-04 | National Center for Geriatrics and Gerontology | Novel oxadiazole derivative and pharmaceutical containing same |
| WO2022069953A1 (en) * | 2020-09-29 | 2022-04-07 | Ranjith Siddaraj | Synthesis and characterization of (s)-3-(5- fluoropyridin-2-yl)-5-(piperidin-3-yl)-l,2,4-oxadiazole derivatives and their secretory phospholipase a2 (spla2) inhibitor activity |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966748A (en) * | 1975-05-08 | 1976-06-29 | American Cyanamid Company | Para-fluorophenyl-N-heterocyclic substituted butanes |
| CN1691944A (zh) * | 2002-08-09 | 2005-11-02 | 阿斯利康(瑞典)有限公司 | 作为代谢型谷氨酸受体－5调节剂的噁二唑 |
| JP2006522128A (ja) * | 2003-04-03 | 2006-09-28 | メルク エンド カムパニー インコーポレーテッド | 代謝調節型グルタミン酸受容体−５のモジュレーターとしての４環イミダゾール誘導体 |
| GB0325956D0 (en) * | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
| SG149900A1 (en) * | 2004-02-18 | 2009-02-27 | Astrazeneca Ab | Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
| GB0510143D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
| GB0510142D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
| GB0510141D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
| GB0510140D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B2 |
| GB0510139D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| GB0622202D0 (en) * | 2006-11-07 | 2006-12-20 | Addex Pharmaceuticals Sa | Novel compounds |
-
2006
- 2006-05-17 WO PCT/IB2006/001881 patent/WO2006123255A2/en not_active Ceased
- 2006-05-17 BR BRPI0611423-7A patent/BRPI0611423A2/pt not_active IP Right Cessation
- 2006-05-17 JP JP2008511821A patent/JP2008540635A/ja active Pending
- 2006-05-17 EP EP06779843A patent/EP1893606A2/en not_active Withdrawn
- 2006-05-17 CA CA002608014A patent/CA2608014A1/en not_active Abandoned
- 2006-05-17 MX MX2007014444A patent/MX2007014444A/es not_active Application Discontinuation
- 2006-05-17 US US11/920,603 patent/US20090215822A1/en not_active Abandoned
- 2006-05-17 EA EA200702469A patent/EA015813B1/ru not_active IP Right Cessation
- 2006-05-17 KR KR1020077029359A patent/KR20080027463A/ko not_active Ceased
- 2006-05-17 NZ NZ564254A patent/NZ564254A/en not_active IP Right Cessation
- 2006-05-17 AU AU2006248655A patent/AU2006248655A1/en not_active Abandoned
-
2007
- 2007-11-06 IL IL187186A patent/IL187186A0/en unknown
- 2007-12-17 NO NO20076478A patent/NO20076478L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006123255A2 (en) | 2006-11-23 |
| EP1893606A2 (en) | 2008-03-05 |
| KR20080027463A (ko) | 2008-03-27 |
| AU2006248655A1 (en) | 2006-11-23 |
| JP2008540635A (ja) | 2008-11-20 |
| WO2006123255A3 (en) | 2007-03-29 |
| EA200702469A1 (ru) | 2008-06-30 |
| CA2608014A1 (en) | 2006-11-23 |
| NZ564254A (en) | 2011-04-29 |
| EA015813B1 (ru) | 2011-12-30 |
| US20090215822A1 (en) | 2009-08-27 |
| BRPI0611423A2 (pt) | 2010-09-08 |
| MX2007014444A (es) | 2008-04-21 |
| NO20076478L (no) | 2008-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL187189A0 (en) | Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors | |
| IL187190A0 (en) | Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors | |
| IL179692A0 (en) | Alkynyl derivatives as modulators of metabotropic glutamate receptors | |
| ZA200908017B (en) | Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) | |
| ZA200908285B (en) | Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842 | |
| EP1855670A4 (en) | BENZAZOLE AMPLIFIERS OF METABOTROPIC GLUTAMATE RECEPTORS | |
| ZA200710668B (en) | Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors | |
| IL204958A0 (en) | Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs) | |
| IL190740A0 (en) | Chromenones and their use as modulators of metabotropic glutamate receptors | |
| IL219149A0 (en) | Novel oxime derivatives and thier use as allosteric modulators of metabotropic glutamate receptors | |
| EP1667983A4 (en) | PYRAZOL MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | |
| IL198931A0 (en) | Benzamide derivatives as ep4 receptor agonists | |
| IL190961A0 (en) | Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase | |
| IL190966A0 (en) | Substituted dihydroisoindolones as allosteric modulators of glucokinase | |
| IL195514A0 (en) | Substituted pyridiyl amide compounds as modulators of the histamine h3 receptor | |
| EP2021004A4 (en) | SUBSTITUTED AZASPIRO DERIVATIVES | |
| EP2355659A4 (en) | Fused Hetereocyclic M1 Receptor Positive Allosmatic Modulators | |
| IL190962A0 (en) | Substituted pyrrolones as allosteric modulators of glucokinase | |
| ZA200710278B (en) | Substituted Oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors | |
| GB0507793D0 (en) | Allosteric modulators of glutamate receptors | |
| HK1142061A (en) | Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor) | |
| HK1148282A (en) | Tetrazole derivates as modulators of metabotropic glutamate receptors (mglurs) | |
| AP2007004176A0 (en) | Novel compounds of amino sulfonyl derivatives | |
| HK1132728A (en) | Benzamide derivatives as ep4 receptor agonists | |
| HK1110806A (en) | Nanoparticulate compositions of heterocyclic amide derivatives |